Aries Drugs Private Limited: Site Master File
Aries Drugs Private Limited: Site Master File
Plot no. 90
Sector-IIDC, Sidcul,
Pant Nagar- 263 145,
UTTARAKHAND,
E-mail : [email protected]
Website : www.ariesdrugs.com
This manufacturing facility has been designed with modern, automated processes, utilities and
equipments conforming to national standards and cGMP norms amended from time to time. Facility has
the capacity to produce complete Oral Liquid Unit. Using modern equipments, This manufacturing
facility is national regulatory compliant and is futuristically designed. In our company has fully
automatic equipments/Instruments for manufacturing. In all department supply fresh air & AHU with
0.5µ filter.
1.2 Manufacture of pharmaceutical products
The facility is dedicated for production of Antibiotics, Multivitamins, Cough Syrup, and
Antialargic. All the above products are manufactured in the following dosage forms in Oral
Liquid :
Manufacturing License No. 17/UA/2009 IN FORM No. 25 and Manufacturing License No.
19/UA/SC/P-2009 in Form No. 28 are issued by Uttarakhand Drug Licensing Authority.
1.3 Our Contact details:
a) Manufacturing Site: b) Head Office :
PLOT NO.90, SECTOR-IIDC, Aries Drugs Pvt. Ltd.
SIDCUL, PANTNAGAR-263145.(U.K) S-89/16, D-Block, Rajajipuram,
E-mail : [email protected] Lucknow-226017.
Website : www.ariesdrugs.com Tel No. 0522-3298260
Mobile : 09335291145/46/47
Tel No : (05944) 250546,
Mobile : 0 9335291146 / 0 9335291145
1.4 Details of our Products and Process:
PRODUCTION FLOW CHARTS
RAW & PACKING MATERIAL MOVEMENT
RM/PM Receipt
De Dusting &
Record Recection. RM
Return to party
Printed PM
Passes
Destroy
Approved
Material store
Dispensing
Primary PM
In-process
Sampling
Testing
Rejection Report
Passes Rejected
LIST OF PRODUCTS
Each 5 ml contain.
7. CETEN SYRUP CETIRIZINE 60 ML
DIHYDROCHLORIDE BP 5mg
Each 5 ml contain.
8. SUPAR SUSPENSION NIMESULIDE B.P. 50mg. 60 ML
PARACETAMOL I.P. 125mg.
Each 5 ml contain.
9. ARO SUSPENSION OFLOXACIN . I.P. 50mg 60 ML
Each 5 ml contain.
10. ARO-OZ SUSPENSION OLFLOXACIN I.P. 50mg. 60 ML
ORNIDAZOLE 125mg.
Each 5 ml contain.
OFLOXACIN I.P. 100mg.
11. AROMET SUSPENSION METRONIDAZOLE BENZOATE 60 ML
(EQ. TO METRONIDAZOLE) I.P. 200mg.
Each 5 ml contain.
CHLORPHENIRAMINE
MALEATE I.P. 2.5mg.
12. ARITONE SYRUP AMMONIUM CHLORIDE I.P. 125mg.
100ML
SODIUM CITRATE I.P. 55mg.
MENTHOL I.P. 1mg.
Each 5 ml contain.
DIPHENHYDRAMINE HCL I.P. 14.08mg.
AMMONIUM CHLORIDE I.P. 138mg.
13 ARYDRYL SYRUP SODIUM CITRATE I.P. 57.03mg. 100 ML
MENTHOL I.P. 1.14mg.
Each 5 ml contain.
BROMHEXINE HCL I.P. 4mg.
GUAIPHENESIN I.P. 50mg.
14. BROX-CZ SYRUP CETIRIZINE 100ML
DIHYDROCHLORIDE B.P. 2.5mg.
MENTHOL I.P. 1mg.
Each 10 ml contain.
SUCRALFATE USP 1mg.
15 ARIFATE –O SUSPENSION OXETACAINE B.P. 10mg. 100ML
Each 5 ml contain.
PARACETAMOL I.P. 125mg.
PHENYLPROPANOLAMINE
16. NOCOLD SYRUP HCL B.P. 2.5mg. 100ML
CHLORPHENIRAMINE
MALEATE I.P. 1mg.
Each 5 ml contain.
CYPROHEPTADINE HCL . I.P. 2mg.
17. CYPOT SYRUP TRICHOLINE CITRATE 0.275gm 200 ML
SORBITOL SOLUTION(70%) I.P. 3.575gm
Each 5 ml contain.
18. CITRAL SYEUP DISODIUM HYDROGEN 100 ML
CITRATE B.P. 1.53gm
Each 5 ml contain.
DEXTROMETHORPHAN
HYDROBROMIDE I.P. 10mg.
PHENYLPROPANOLAMINE
19. ARICOF SYRUP HCL B.P 10mg.
100 ML
CHLORPHENIRAMINE
MALEATE I.P 2mg.
MENTHOL I.P. 1.5mg
Each 5 ml contain.
NIMESULIDE B.P. 50mg.
20. NSP SUSPENSION PARACETAMOL I.P. 125mg. 60ML
Each 5 ml contain.
DRIED ALUMINIUM
21. ARICID SUSPENSION HYDROXIDE GEL I.P. 200mg. 170ML
MAGNESIUM HYDROXIDE I.P. 200mg.
SIMETHICONE I.P. 25mg.
Each 5 ml contain.
22 OFCIN SUSPENSION OFLOXACIN . I.P. 50mg.
60 ml
Each 5 ml contain.
23. OFCIN-OZ SUSPENSION OFLOXACIN I.P. 50mg. 60ML
ORNIDAZOLE 125mg.
Each 5 ml contain.
CYPROHEPTADINE HCL . I.P. 2mg.
24. LIVOTOP SYRUP TRICHOLINE CITRATE 0.275gm 200ML
SORBITOL SOLUTION(70%) I.P. 3.575gm
Each 5 ml contain.
CHLORPHENIRAMINE
MALEATE I.P. 2.5mg.
25. LCTONE SURUP AMMONIUM CHLORIDE I.P. 125mg. 100ML
SODIUM CITRATE I.P. 55mg.
MENTHOL I.P. 1mg.
Each 10 ml contain.
26. ARIFATE SUSPENSION SUCRALFATE USP 1gm. 100ML
Each 5 ml contain.
FUNGAL DIASTASE(1:1200) I.P. 50mg.
27. PEPZYME SYRUP PEPSIN(1:3000) I.P. 10mg 200ML
Each 5 ml contain.
FERROUS GLUCONATE I.P. 300mg.
28. CALCITONE-F SYRUP CALCIUM GLUCONATE I.P. 125mg. 200ML
CYANOCOBALMINE I.P. 10mcg.
FOLIC ACID I.P. 1.5mg
Each 5 ml contain.
CARBONYL IRON EQ. TO
ELEMENTAL IRON 60mg.
29. CARBOZ-SYRUP VIT. B12 I.P. 7.5mcg. 200ML
FOLIC ACID I.P. 0.75mg.
ZINC(as zinc sulphate I.P.) 11.25mg.
1.6 Site Synopsis:
The site is situated at Integrated Industrial Estate, Pant Nagar about 5 km away from Rudrapur
city (Uttarakhand). It is accessible by rail as well as by road, about 237 km from Delhi, and
about 300 km from Dehradun. The total area of the plot is approximately 1971.40 sq. yard. The
plot is situated in pollution free environment.
Production staff
1. 04
Quality Control
2. 03
Engineering Services
4. 02
Stores
5. 02
Administration
6. 03
Security
7. 02
House keeping
9. 05
Regulatory 01
10.
11 Operator 05
Total 27
2.0 PERSONNEL
2.1 LIST OF KEY TECHNICAL PERSONNEL AT PANTNAGAR SITE
Manufacturing facilities are segregated as per cGMP norms and separate buildings have been
provided for Specialty Formulations, Oral Liquid Section.
3.2 Nature of construction and fixtures / fittings:
Nature of construction : Brick & RCC
External finish : Cement plaster with snowcem finish
Internal Finish : The manufacturing areas are made up of
a. Stone Flooring
b. Polyurethane coatings on walls and ceilings.
In other areas, Internal walls and ceilings are plastered with cement to smooth finish and painted
with glossy washable antibacterial and antifungal paint. Peripheral areas, which are other than
the production areas, are constructed by civil structure.
The preventive maintenance of the systems, building and premises including painting is carried
out as per schedule.
The ventilation and water systems are periodically serviced and checked for overall
performance.
Records are maintained as follows:
The equipments are divided into -
a) Utility Equipments
b) Production Equipments
Preventive maintenance documents are maintained separately. The schedule for preventive
maintenance is formulated on annual basis for each manufacturing unit with specific break up of
weekly / fortnightly / monthly / quarterly and half-yearly maintenance schedules.
A list of major equipments and machinery used in production has been attached.
3.6 Validation and Calibration
Validation Master Plan is prepared by QC in line with the philosophy of Aries Drugs Private
Limited to plan and execute validation activities in the facility according to Validation Matrix.
All critical equipments, instruments and utilities are subjected to followed by DQ, IQ, OQ and
PQ. In case of any changes, revalidation is performed accordingly.
Records are kept with detailed information for each equipment such as details of calibration
standards and limits, responsibilities for performing calibration, intervals between calibration,
record-keeping requirements and logs, and actions to be taken. The following validations are
carried out:
• Water Validation
• Equipment Validation
• QC Instrument / Analytical Method Validation
Calibration of equipments by external agencies is carried out periodically and the tag indicating
next calibration due is affixed on individual equipment.
3.7 SANITATION
Sanitation and Cleaning to ensure that the system is cleaned properly to be free from product,
detergent and microbial flora to specified level to prevent contamination.
Written guidelines and procedures for cleaning specifications, cleaning agents and their
concentration to be used are available.
In critical process areas, the equipments / machinery have been provided with CIP and SIP
systems. Written SOPs are in place for cleaning and sanitization of manufacturing areas.
Separate SOPs are available for cleaning of individual equipment / machinery, which are
followed, & records are maintained thereof.
4.0 DOCUMENTATION
4.1 Documentation is an essential part of the Quality Assurance/Quality Control System. Its purpose
is to define the system control and to specify / record various activities carried out and to ensure
effective implementation.
Documentation system includes the history for each batch of product. It includes the
information on utilization and processing of starting materials, packaging materials and
intermediate, bulk and finished products.
Master documents such as Master Specification, Master Formula Card and Master File for each
raw material, packing material and finished product are available with QA/QC department.
5.0 PRODUCTION
5.1 Materials are procured from approved vendors against purchase order. The materials received at
warehouse are cleaned free of dust by vacuum cleaner, checked for physical defects and kept in
quarantine till QC sampling is done. After the QC Report, approved materials are shifted to
Approved Area and if rejected, transferred to Rejected Materials Area. Rejected materials are
kept under lock and key till they are returned to the vendor in case of raw materials and till they
are destroyed, in case of printed packing materials.
QC sampling and dispensing of raw materials is done under the specified areas. Dispensed
materials are moved to ‘Day Store’ till taken up for production.
After production, the finished goods are maintained in the quarantine pending QC release. Once
the QC release is obtained, the finished products are transferred to BSR.
FACILITIES:
Documentation (cGMP)
Latest Equipment/Instruments for manufacturing.
AHU with 0.5µ filter.
Fresh air system
Cooling system
Fresh air & AHU with 0.5µ filter In Manufacturing & packing area.
5.2 Flow sheets ORAL LIQUID PRODUCTION
BATCH MANUFACTURING
RECORD
RAW MATERIAL
REQUISITION
(FORMULATION ORDER)
DISPENSING OF RAW
MATERIALS
MANUFACTURING
PROCESS
BULK
SAMPLING TESTING
QC RELEASE
IPQC
FILLING PACKING MATERIAL
REQUISITION
LABELING
SAMPLING &
INSPECTION
QC RELEASE
TRANSFER TO
STORE
DEPARTMENT
5.3 LIST OF MAJOR EQUIPMENT AT PLANT
6.1 Quality control shall deal with sampling, specifications, testing, documentation, release
procedure and ensure implementation of the relevant protocol
The QC Lab has got the following sections:
• Chemical
• Instrumentation
• Packing materials testing
• Microbiology
• Re-agents and storage
• Control Samples
• Record Room
• Heating Equipments Area
• Stability Studies
• Wash Area
6.2 FACILITIES
General facilities
Separate Room and cupboards are provided for storing the samples before and after
analysis. All analytical data are entered in a prescribed protocol sheet based on which a
test report is prepared. The data are filed according to the serial number of COA.
Administrative and personnel facilities
The role of Quality Quality Control is to ensure design and development of pharmaceutical
products taking into account the requirements of Good Manufacturing Practices (GMP), Good
Laboratory Practices (GLP) Good Documentation Practices (GDP). Adequate controls on
starting materials, bulk products and other in-process controls, calibrations and validations are
carried out.
The effective quality management is achieved through systematic sampling, testing, validating
and monitoring of materials, facilities, systems and procedures, which can have direct impact on
the quality of the products throughout their shelf life. Much importance is given to in-process
controls on the guidelines given under Process The Standard Operating Procedures (SOPs), duly
authorized for all operations including Production, Quality Control, Distribution, Safety,
Environmental Control, Housekeeping and Engineering are the other important part of Quality
Management System.
Self-inspection and Audits are part of effective implementation of Quality Management
System. Inspection, evaluation, rating and approval of vendors for supplies of raw
materials, excipients and packing materials are carried out in conformity to the Good
Manufacturing Practices.
6.4 LIST OF EQUIPMENTS / INSTRUMENTS IN QA/QC LAB
DISPENSING
BULK SOLUTION
Description
pH
Fill volume
Wt./ml
Assay
TEST:
1- PHARMACOPOEAL SPECIFICATIONS
2- IN HOUSE SPECIFICATIONS
6.6 PACKAGING MATERIAL ANALYSIS AND RELEASE
PRIMARY SECONDARY
Documentation
Separate Under Test area with yellow coloured mark on floor.
Separate Approved area with Green coloured mark on floor.
Separate Rejected area with Red coloured mark on floor.
Cooling area
Dispensing & Sampling Booth with LAF
Cold storage area for Multivitamins and other raw material.
Finish goods storage area.
Primary & Secondary Packing materials area.
The auditors prepare internal audit reports and the concerned Department Head is required to
submit the corrective action plan.
External experts are also called periodically to evaluate our working on the principles of GMP,
GLP, GDP.
10.0 ORGANIZATION CHART:
_________________________________________________________